Stenberg VY, Liukaityte R, Kristiansen SK, Wangen-Riise R, Kleinauskas A, Dunne V, Juzeniene A (2025)
Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [²¹²Pb]Pb-AB001
Sci Rep (in press)
DOI 10.1038/s41598-025-29785-7, PubMed 41318731

Arous D, Larsen Lie J, Jeppesen Edin NF, Malinen E (2025)
Integrating 2D dosimetry and cell survival analysis for predicting local effect in spatially fractionated radiotherapy
Acta Oncol, 64, 1465-1472
DOI 10.2340/1651-226X.2025.44599, PubMed 41132002

Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Tasken KA (2025)
Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients
Acta Oncol, 64, 1446-1454
DOI 10.2340/1651-226X.2025.43970, PubMed 41123130